Log In
BCIQ
Print this Print this
 

Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)

BCIQ
Print ChartPrint this
1 - Cancer 1 - Hematology 1 - Inflammation 1 - Cancer 3 - Autoimmune 2 - Cancer 1 - Autoimmune
Phase of DevelopmentPhase IPhase IIPhase IIIMarketed
Autoimmune

1

3

-

-

Cancer

2

1

-

1

Hematology

-

-

1

-

Inflammation

-

1

-

-




 Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$2,949.9M

$102.5M

$12.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today